Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 5/12/23 → 5/12/27 |
Funding
- H. Lundbeck A/S: $62,986.00
19379A: Long-term, Open-label (dose-blinded), Extension study of Eptinezumab in Children and Adolescents with Chronic or Episodic Migraine
- Qaiser, Sharoon (PI)